Skip to main content
Top
Published in: Head and Neck Pathology 2/2007

01-12-2007 | Original Research

p63 Immunohistochemistry Differentiates Salivary Gland Oncocytoma and Oncocytic Carcinoma from Metastatic Renal Cell Carcinoma

Authors: Jonathan B. McHugh, Aaron P. Hoschar, Mari Dvorakova, Anil V. Parwani, E. Leon Barnes, Raja R. Seethala

Published in: Head and Neck Pathology | Issue 2/2007

Login to get access

Abstract

Metastatic renal cell carcinoma (RCC) can pose diagnostic challenges in the head and neck often resembling benign and malignant oncocytic lesions. Immunohistochemical panels have been reported to help with this differential but are not entirely specific or sensitive. We have noticed that p63 routinely stains salivary gland oncocytomas but not metastatic RCC. Nineteen oncocytomas, 9 cases of oncocytosis, 9 oncocytic carcinomas and 16 head and neck metastatic RCC were studied. Morphologic features evaluated were cytoplasmic character (clear versus oncocytic), Fuhrman nuclear grade, mitotic rate, growth pattern, presence of lumens/blood lakes and stromal characteristics. Tumors were stained with antibodies to p63, renal cell carcinoma marker (RCCm), CD10, and vimentin. Eight benign oncocytic tumors (29%) had clear cell features while 6 metastatic RCC (37%) had oncocytic features. Median Fuhrman nuclear grade was 2 in oncocytoma and oncocytosis and 3 both oncocytic carcinoma and metastatic RCC. Mitotic rates were only significantly different between benign oncocytic tumors and metastatic RCC. All oncocytomas had lumina compared to half of metastatic RCC, all of which also demonstrated blood lakes. Seven benign oncocytic tumors (25%) and 5 oncocytic carcinomas (56%) had RCC-like vascular stroma. All primary salivary gland tumors were positive for p63, predominately in basal cell-type distribution. None of the metastatic RCC was positive. RCCm was entirely specific but lacked sensitivity for metastatic RCC while CD10 and vimentin showed variable sensitivity and specificity. While clinical history and morphology usually are adequate, demonstration of p63 staining can definitively exclude metastatic RCC from the differential diagnosis of similar appearing tumors in salivary glands, namely oncocytoma and oncocytic carcinoma, with 100% specificity and sensitivity. While RCCm, CD10, and vimentin performed adequately, they were significantly less reliable than p63 with both false positives and false negatives.
Literature
1.
go back to reference Tandler B, Hutter RV, Erlandson RA. Ultrastructure of oncocytoma of the parotid gland. Lab Invest 1970;23:567–80PubMed Tandler B, Hutter RV, Erlandson RA. Ultrastructure of oncocytoma of the parotid gland. Lab Invest 1970;23:567–80PubMed
2.
go back to reference Palmer TJ, Gleeson MJ, Eveson JW, et al. Oncocytic adenomas and oncocytic hyperplasia of salivary glands: a clinicopathological study of 26 cases. Histopathology 1990;16:487–93PubMedCrossRef Palmer TJ, Gleeson MJ, Eveson JW, et al. Oncocytic adenomas and oncocytic hyperplasia of salivary glands: a clinicopathological study of 26 cases. Histopathology 1990;16:487–93PubMedCrossRef
3.
go back to reference Ellis G, Auclair P. Atlas of tumor pathology. Tumors of the salivary glands. 3rd ed. Washington DC: Armed Forces Institute of Pathology; 1996 Ellis G, Auclair P. Atlas of tumor pathology. Tumors of the salivary glands. 3rd ed. Washington DC: Armed Forces Institute of Pathology; 1996
4.
go back to reference Brandwein MS, Huvos AG. Oncocytic tumors of major salivary glands. A study of 68 cases with follow-up of 44 patients. Am J Surg Pathol 1991;15:514–28PubMedCrossRef Brandwein MS, Huvos AG. Oncocytic tumors of major salivary glands. A study of 68 cases with follow-up of 44 patients. Am J Surg Pathol 1991;15:514–28PubMedCrossRef
6.
go back to reference Wang B, Brandwein M, Gordon R, et al. Primary salivary clear cell tumors—a diagnostic approach: a clinicopathologic and immunohistochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelial-myoepithelial carcinoma. Arch Pathol Lab Med 2002;126:676–85PubMed Wang B, Brandwein M, Gordon R, et al. Primary salivary clear cell tumors—a diagnostic approach: a clinicopathologic and immunohistochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelial-myoepithelial carcinoma. Arch Pathol Lab Med 2002;126:676–85PubMed
7.
go back to reference Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol 2007;31:44–57PubMedCrossRef Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol 2007;31:44–57PubMedCrossRef
8.
go back to reference Maiorano E, Altini M, Favia G. Clear cell tumors of the salivary glands, jaws, and oral mucosa. Semin 1997;14:203–12 Maiorano E, Altini M, Favia G. Clear cell tumors of the salivary glands, jaws, and oral mucosa. Semin 1997;14:203–12
9.
go back to reference Ozolek JA, Bastacky SI, Myers EN, et al. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma. Laryngoscope 2005;115:1097–100PubMedCrossRef Ozolek JA, Bastacky SI, Myers EN, et al. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma. Laryngoscope 2005;115:1097–100PubMedCrossRef
10.
go back to reference Ellis G, Auclair P, Gnepp D, et al. Surgical pathology of the salivary glands. Philadelphia: W.B. Sanders; 1991 Ellis G, Auclair P, Gnepp D, et al. Surgical pathology of the salivary glands. Philadelphia: W.B. Sanders; 1991
11.
go back to reference Capone RB, Ha PK, Westra WH, et al. Oncocytic neoplasms of the parotid gland: a 16-year institutional review. Otolaryngol Head Neck Surg 2002;126:657–62PubMedCrossRef Capone RB, Ha PK, Westra WH, et al. Oncocytic neoplasms of the parotid gland: a 16-year institutional review. Otolaryngol Head Neck Surg 2002;126:657–62PubMedCrossRef
12.
go back to reference Chang A, Harawi SJ. Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu 1992;27 Pt 1:263–304PubMed Chang A, Harawi SJ. Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu 1992;27 Pt 1:263–304PubMed
13.
go back to reference Goode RK, Corio RL. Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol 1988;65:61–6PubMedCrossRef Goode RK, Corio RL. Oncocytic adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol 1988;65:61–6PubMedCrossRef
14.
go back to reference Nakada M, Nishizaki K, Akagi H, et al. Oncocytic carcinoma of the submandibular gland: a case report and literature review. J Oral Pathol Med 1998;27:225–8PubMedCrossRef Nakada M, Nishizaki K, Akagi H, et al. Oncocytic carcinoma of the submandibular gland: a case report and literature review. J Oral Pathol Med 1998;27:225–8PubMedCrossRef
15.
go back to reference Boles R, Cerny J. Head and neck metastases from renal carcinomas. Mich Med 1971;70:616–8PubMed Boles R, Cerny J. Head and neck metastases from renal carcinomas. Mich Med 1971;70:616–8PubMed
16.
go back to reference Pritchyk KM, Schiff BA, Newkirk KA, et al. Metastatic renal cell carcinoma to the head and neck. Laryngoscope 2002;112:1598–602PubMedCrossRef Pritchyk KM, Schiff BA, Newkirk KA, et al. Metastatic renal cell carcinoma to the head and neck. Laryngoscope 2002;112:1598–602PubMedCrossRef
17.
go back to reference Cheng ET, Greene D, Koch RJ. Metastatic renal cell carcinoma to the nose. Otolaryngol Head Neck Surg 2000;122:464PubMedCrossRef Cheng ET, Greene D, Koch RJ. Metastatic renal cell carcinoma to the nose. Otolaryngol Head Neck Surg 2000;122:464PubMedCrossRef
18.
go back to reference Miyamoto R, Helmus C. Hypernephroma metastatic to the head and neck. Laryngoscope 1973;83:898–905PubMedCrossRef Miyamoto R, Helmus C. Hypernephroma metastatic to the head and neck. Laryngoscope 1973;83:898–905PubMedCrossRef
19.
go back to reference Owens RM, Friedman CD, Becker SP. Renal cell carcinoma with metastasis to the parotid gland: case reports and review of the literature. Head Neck 1989;11:174–8PubMedCrossRef Owens RM, Friedman CD, Becker SP. Renal cell carcinoma with metastasis to the parotid gland: case reports and review of the literature. Head Neck 1989;11:174–8PubMedCrossRef
20.
go back to reference Rees R, Maples M, Lynch JB, et al. Malignant secondary parotid tumors. South Med J 1981;74:1050–2PubMed Rees R, Maples M, Lynch JB, et al. Malignant secondary parotid tumors. South Med J 1981;74:1050–2PubMed
21.
22.
go back to reference Seifert G, Hennings K, Caselitz J. Metastatic tumors to the parotid and submandibular glands–analysis and differential diagnosis of 108 cases. Pathol Res Pract 1986;181:684–92PubMed Seifert G, Hennings K, Caselitz J. Metastatic tumors to the parotid and submandibular glands–analysis and differential diagnosis of 108 cases. Pathol Res Pract 1986;181:684–92PubMed
23.
go back to reference Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305–16PubMedCrossRef Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2:305–16PubMedCrossRef
24.
go back to reference Parsa R, Yang A, McKeon F, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113:1099–1105PubMedCrossRef Parsa R, Yang A, McKeon F, et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113:1099–1105PubMedCrossRef
25.
go back to reference Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714–8PubMedCrossRef Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398:714–8PubMedCrossRef
26.
go back to reference Barbareschi M, Pecciarini L, Cangi MG. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054–60PubMedCrossRef Barbareschi M, Pecciarini L, Cangi MG. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054–60PubMedCrossRef
27.
go back to reference Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280–9PubMedCrossRef Reis-Filho JS, Schmitt FC. Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker. Adv Anat Pathol 2002;9:280–9PubMedCrossRef
28.
go back to reference Yang A, Kaghad M, Caput D, et al. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90–5PubMedCrossRef Yang A, Kaghad M, Caput D, et al. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 2002;18:90–5PubMedCrossRef
29.
go back to reference Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 2002;441:428–36PubMedCrossRef Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch 2002;441:428–36PubMedCrossRef
30.
go back to reference Bilal H, Handra-Luca A, Bertrand J-C, et al. p63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51:133–9PubMed Bilal H, Handra-Luca A, Bertrand J-C, et al. p63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 2003;51:133–9PubMed
31.
go back to reference Foschini MP, Gaiba A, Cocchi R, et al. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Int J Surg Pathol 2005;13:329–5PubMedCrossRef Foschini MP, Gaiba A, Cocchi R, et al. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Int J Surg Pathol 2005;13:329–5PubMedCrossRef
32.
go back to reference Seethala RR, LiVolsi VA, Zhang PJ, et al. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 2005;27:696–702PubMedCrossRef Seethala RR, LiVolsi VA, Zhang PJ, et al. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 2005;27:696–702PubMedCrossRef
33.
go back to reference Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78:2281–7PubMedCrossRef Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78:2281–7PubMedCrossRef
34.
go back to reference Langner C, Ratschek M, Tsybrovskyy O, et al. p63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003;51:1097–9PubMed Langner C, Ratschek M, Tsybrovskyy O, et al. p63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003;51:1097–9PubMed
35.
go back to reference Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494–501PubMed Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494–501PubMed
36.
go back to reference Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001;116:823–30PubMedCrossRef Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001;116:823–30PubMedCrossRef
Metadata
Title
p63 Immunohistochemistry Differentiates Salivary Gland Oncocytoma and Oncocytic Carcinoma from Metastatic Renal Cell Carcinoma
Authors
Jonathan B. McHugh
Aaron P. Hoschar
Mari Dvorakova
Anil V. Parwani
E. Leon Barnes
Raja R. Seethala
Publication date
01-12-2007
Publisher
Humana Press Inc
Published in
Head and Neck Pathology / Issue 2/2007
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-007-0031-4

Other articles of this Issue 2/2007

Head and Neck Pathology 2/2007 Go to the issue

Sine qua none Radiology-Pathology

Head Neck Pathol Radiology Pathology Classics

Sine qua none Radiology-Pathology

Glandular Odontogenic Cyst